Small Cell Lung Cancer p53 Hotspot Mutation Cell Panel (ATCC® TCP-2040)

Organism: Homo sapiens, human  / 

Organism Homo sapiens, human
NCI-H1882, ATCC CRL-5903
NCI-H1417, ATCC CRL-5869
NCI-H719, ATCC CRL-5837
NCI-H1105, ATCC CRL-5856
NCI-H1048, ATCC CRL-5853
Biological understanding of top genetic alterations across tumor types
Novel anti-cancer drug targeting
Reactivation of mutant p53
Studies related to p53 molecular mechanisms
Testing small molecules or biologics for cancer drug development
Type Strain no
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Small Cell Lung Cancer p53 Hotspot Mutation Cell Panel is comprised of 6 select cell lines derived from the lung that have been sequenced and validated by ATCC. The panel includes both WT p53 cell lines as well as cultures with p53 hotspot mutations at codons 175, 248, 249, or 273.
Product Format frozen
Storage Conditions LN vapor (less than -130°C) only